2015
DOI: 10.1097/mat.0000000000000190
|View full text |Cite
|
Sign up to set email alerts
|

Preservation of Native Aortic Valve Flow and Full Hemodynamic Support with the TORVAD Using a Computational Model of the Cardiovascular System

Abstract: This paper describes the stroke volume selection and operational design for the TORVAD™, a synchronous, positive-displacement ventricular assist device (VAD). A lumped parameter model was used to simulate hemodynamics with the TORVAD™ compared to those under continuous flow VAD support. Results from the simulation demonstrated that a TORVAD™ with a 30 mL stroke volume ejecting with an early diastolic counterpulse provides comparable systemic support to the HeartMate II® (HMII) (cardiac output 5.7 L/min up from… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 39 publications
0
8
0
1
Order By: Relevance
“…The inputs to the model are patient size and HF severity, for which the stroke volume and synchronous operation of the TORVAD can be optimized. This model has been previously used to determine the stroke volume and synchronous operation timing for an adult in end-stage HF (30 mL with an early diastolic synchronous counterpulse) (18). For the purposes of this design, the model has been adapted for pediatric HF by changing model parameters (e.g., systemic volume, vascular resistance, heart rate, left ventricular size and contraction (2528)), allowing for prediction of the level of support and pump stroke volume that would be needed for children with BSAs between 0.6 and 1.5 m 2 .…”
Section: Design Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The inputs to the model are patient size and HF severity, for which the stroke volume and synchronous operation of the TORVAD can be optimized. This model has been previously used to determine the stroke volume and synchronous operation timing for an adult in end-stage HF (30 mL with an early diastolic synchronous counterpulse) (18). For the purposes of this design, the model has been adapted for pediatric HF by changing model parameters (e.g., systemic volume, vascular resistance, heart rate, left ventricular size and contraction (2528)), allowing for prediction of the level of support and pump stroke volume that would be needed for children with BSAs between 0.6 and 1.5 m 2 .…”
Section: Design Resultsmentioning
confidence: 99%
“…The primary synchronous operation mode of the TORVAD is an early diastolic counterpulse (18). By operating the pump in this mode, it briefly ceases to pump blood in systole, allowing the ventricle to eject normally through the aortic valve.…”
Section: Introductionmentioning
confidence: 99%
“…In a lumped parameter model, a TORVAD with a 30-mL stroke volume ejecting with an early diastolic counterpulse provides comparable systemic support to the HeartMate II (Abbott Inc, Chicago, IL, USA) by taking advantage of synchronous pulsatility with preserved pulse pressure. 46 This pump also showed significantly less blood trauma and markedly lower shear stress than current CF LVADs. We are now developing an advanced ventricular assist device, which is able to generate greater levels of pulsatility and possessing a shut-off feature with the additional ability to modulate the axial position of a rotor by pressure differences in the inlet and outlet.…”
Section: Generating Pfmentioning
confidence: 90%
“…The pump performs blood aspiration and ejection by cyclically actuating a piston around a toroidal pumping chamber via magnetic coupling to a motor while maintaining a second piston in a stationary position to occlude blood flow between the inlet and outlet ports. In a lumped parameter model, a TORVAD with a 30‐mL stroke volume ejecting with an early diastolic counterpulse provides comparable systemic support to the HeartMate II (Abbott Inc, Chicago, IL, USA) by taking advantage of synchronous pulsatility with preserved pulse pressure . This pump also showed significantly less blood trauma and markedly lower shear stress than current CF LVADs.…”
Section: New Durable Mcs Devices Generating Pfmentioning
confidence: 99%
“…[7], [25] - [27]. Puede comprobarse el desarrollo y perfeccionamiento de muy buenos modelos, pero que pueden ser utilizados bajo muy pocas situaciones.…”
Section: Discussionunclassified